Navigation Links
A treatment for Osteoporosis

The bone- strengthening drug fosamax (Bifosa) was initially lauded as a major breakthrough for women with osteoporosis. But doctors discovered that patients often stopped their// prescription because of the drug's rigid dosing instructions: It was supposed to be taken upon waking 30 minutes before eating, and downed with plenty of water. To top it off, the drug can cause severe indigestion.

So scientists tried giving women a week's dose at once, enrolling 1200 postmenopausal women with osteoporosis in a two-year international trial (medical centres from the US to France participated).

They found that taking one pill a week could protect bone just as well. And related research, a four- year survey of 180 patients, confirmed everyone's suspicion: People are far more likely to stick with a once-a-week schedule. The drug has already been approved for weekly dosage by the US government.


'"/>




Page: 1

Related medicine news :

1. Thyroid hormone treatment hastens recovery after cardiac surgery
2. Feeding channel created by malaria parasite - a new target for malaria treatments
3. Now umbilical cord helps in stroke treatment.
4. Now AIDS treatment comes dirt-cheap
5. Breast cancer treatment to be determined by gene test
6. Hemopurifier may revolutionise AIDS treatment
7. New drug helps boost cancer treatment
8. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
9. Experimental treatment for Ebola Virus Shows promising results in mice
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. New dimension in the treatment of female sexual dysfunction

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: treatment for Osteoporosis

(Date:11/20/2009)... , CHICAGO, Nov. 20 ... the U.S. Food and Drug Administration (FDA) to es...ening chemicals. ,, Citing concern about the s...tered without the benefit of professional consulta...said that the application of chemically based toot...
(Date:11/20/2009)... , WINSTON-SALEM, N.C., Nov. 20 /PRNewswire-US... is on a mission to redefine what it means to be "...onal counselor with a specialty in family counseli...ke Forest University, Gladding says research shows...ads to sadness and even depression during the holi...
(Date:11/20/2009)... editorial published online November 20 in the Jo...the exaggerated fears and hopes that often appear ... provides guidance for both the media and journals...tz, M.D., M.S., and Steven Woloshin, M.D., M.S., o...th Institute for Health Policy and Clinical Practi...
(Date:11/20/2009)...eattle, Washington) November 20, 2009Emergency med...assess an estimated 350,000 cardiac arrests each y...en cardiac arrest survive. Better quality cardiop...al EMS providers may be associated with better pat...um (ROC) is the largest clinical research network ...
(Date:11/20/2009)...umers save up to one-third buying 90-day supply, s...y News) -- Buying a three-month supply of prescrip...a one-month supply, according to a new study. ,...lled for 395 drugs between 2000 and 2005, and foun...stead of a one-month supply saved an average 29 pe...
Breaking Medicine News(10 mins):Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3Health News:Three-Month Supply Lowers Drug Costs 2
...expected to open in 2011 and bring 600 new jobs to...rmacy, America,s largest retail pharmacy, announce...,000 square foot distribution center in Chemung Co...would support the inventory and fulfillment needs ...
... A new medical marketing website recent...ractices strengthen their marketing strategies and...specializes in giving medical practices the edge n...rch of a customized approach to medical marketing...
...China, Feb. 5 /PRNewswire-Asia-FirstCall/ -- Sheng...) ("Shengtai" or "the Company"),a leading manufact...al grade,glucose products in China, today commente...l services. Over the next three years,the multi-bi...
...N.J., Feb. 5 Tibotec, Inc. today announced it has...g Administration (FDA) seeking traditional approva...cleoside reverse transcriptase inhibitor (NNRTI). ...in the U.S. by Tibotec Therapeutics, a division of...
...ass., Feb. 5 Palomar Medical Technologies, Inc. (...er of light-based systems for cosmetic treatments,...quarter and year ended December 31, 2008. Revenue...illion were funded development revenues, and $1.25...
...fantis(R) meets high standards set by independent ...edible probiotic products , , CINCINNATI, Feb. 5 ...terday by The International Scientific Association...city, clinical proof, packaging, and the quality a...
Other Medicine News:Health News:CVS/pharmacy Announces Plans for New Distribution Center in Southern New York 2Health News:Medical Marketing Firm Builds Service Provider and Medical Practice Bottom Lines 2Health News:Medical Marketing Firm Builds Service Provider and Medical Practice Bottom Lines 3Health News:Shengtai Pharmaceutical, Inc. Comments on China's Recently Approved Health Care Reform Plan 2Health News:Shengtai Pharmaceutical, Inc. Comments on China's Recently Approved Health Care Reform Plan 3Health News:Tibotec Submits Application to U.S. Food and Drug Administration Seeking Traditional Approval for INTELENCE(TM) (etravirine) 2Health News:Tibotec Submits Application to U.S. Food and Drug Administration Seeking Traditional Approval for INTELENCE(TM) (etravirine) 3Health News:Tibotec Submits Application to U.S. Food and Drug Administration Seeking Traditional Approval for INTELENCE(TM) (etravirine) 4Health News:Tibotec Submits Application to U.S. Food and Drug Administration Seeking Traditional Approval for INTELENCE(TM) (etravirine) 5Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 2Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 3Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 4Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 5Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 6Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 7Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 8Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 9Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 10Health News:Align(R) Daily Probiotic Supplement Meets New Consumer Guidelines 2Health News:Align(R) Daily Probiotic Supplement Meets New Consumer Guidelines 3Health News:Align(R) Daily Probiotic Supplement Meets New Consumer Guidelines 4
(Date:11/20/2009)...ov. 20 Smith & Nephe... to announce the signing of a technology developme...efense that may lead to the creation of a fracture...atment of the limbs of soldiers who sustain battle...ced Research Projects Agency (DARPA), the central ...
(Date:11/19/2009)... Nov. 19 In a series of ...ce, Heska Corporation (Nasdaq: HSKA ) ("Heska" or...new and improved website. The upgraded site is th... programming to align the site with the company,s ...Logo: http://www.newscom.com/cgi-bin/prnh/200006...
(Date:11/19/2009)..., Nov. 19 Ligon Discovery, Inc., w...chnology to find drugs against high-value targets,...nancing led by incTANK Ventures. The company will ...campaign that will screen over 100 high-value dise... Ventures General Partner Christian Bailey joins t...
Breaking Medicine Technology:Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3Cambridge-based Ligon Discovery Raises $1M in Seed Funding 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 3Heart Drug Combos Raise Risk of Gastrointestinal Bleeding 47680 1Heart Drug Combos Raise Risk of Gastrointestinal Bleeding 47680 2Halogen Delivers Talent Management Industry 26apos 3Bs Most Comprehensive Value Add Content for Healthcare Customers 47676 1Halogen Delivers Talent Management Industry 26apos 3Bs Most Comprehensive Value Add Content for Healthcare Customers 47676 2Halogen Delivers Talent Management Industry 26apos 3Bs Most Comprehensive Value Add Content for Healthcare Customers 47676 3Halogen Delivers Talent Management Industry 26apos 3Bs Most Comprehensive Value Add Content for Healthcare Customers 47676 4When evolution is not so slow and gradual 8702 1When evolution is not so slow and gradual 8702 2
...on,s Immunization Project aims to, raise awarene...on, and increase vaccine complia.../-- The COSHAR Foundation, a,nonprofit organizatio...mpowerment with a focus on minority and disadvanta...ion awareness campaign, Protecting our Future:,The...
...23 ,Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ),...ery and development of drugs for the treatment of,...nnounced preclinical data,from the company,s polym...tment of hepatitis C. These data are being present...on for the Study of the Liver (EASL) being,held th...
Other Medicine Technology:The COSHAR Foundation Launches National Childhood Immunization Awareness Campaign During National Infant Immunization Week (April 19-26) 2The COSHAR Foundation Launches National Childhood Immunization Awareness Campaign During National Infant Immunization Week (April 19-26) 3Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL) 2Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL) 3Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL) 4
Complete brand Blink-N-Clean Lens Drops
Renu Rewetting Drops
Softwear Saline
Sensitive Eyes Sterile Saline Spray
Medicine Products: